
Glimidac-MV1 Tablet SR
Marketer
Daksh Pharma Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimidac-MV1 Tablet SR
Diabetac-Comb SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetac-Comb SR should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, alongside periodic blood tests to assess blood cell counts and liver function.
Uses of Glimidac-MV1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimidac-MV1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimidac-MV1 Tablet SR on an empty stomach.
Common Side effects of Glimidac-MV1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimidac-MV1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimidac-MV1 Tablet SR on an empty stomach.
How Glimidac-MV1 Tablet SR works:
Extended-release Glimidac-MV1 tablets contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimidac-MV1 Tablet SR use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimidac-MV1 tablet might pose pregnancy risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimidac-MV1 tablet likely poses a risk during lactation. Available human data indicate potential transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimidac-MV1 Tablet SR is likely inadvisable for individuals with kidney impairment and should be omitted. Physician consultation is recommended. Furthermore, Glimidac-MV1 Tablet SR is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Exercise caution when prescribing Glimidac-MV1 Tablet SR to patients with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. A low initial dose of Glimidac-MV1 Tablet SR is typically recommended for individuals with mild to moderate liver disease; its use is contraindicated in those with severe liver dysfunction.
What if you forget to take Glimidac-MV1 Tablet SR :
Should you forget a Glimidac-MV1 Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimidac-MV1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
